- Home
- MAC
as 06-20-2025 4:00pm EST
Macerich invests in premium mall assets. The company owns 30 regional malls in its consolidated portfolio and 10 regional malls in its unconsolidated portfolio along with two power centers and seven other real estate assets. The company's total portfolio has 42.9 million square feet of gross leasable area and averaged $837 sales per square foot over the 12 months ended in December 2024.
| Founded: | 1964 | Country: | United States |
| Employees: | N/A | City: | SANTA MONICA |
| Market Cap: | 4.0B | IPO Year: | 1994 |
| Target Price: | $18.40 | AVG Volume (30 days): | 1.7M |
| Analyst Decision: | Hold | Number of Analysts: | 11 |
| Dividend Yield: | Dividend Payout Frequency: | Quarterly | |
| EPS: | -0.51 | EPS Growth: | N/A |
| 52 Week Low/High: | $12.48 - $22.27 | Next Earning Date: | 07-30-2025 |
| Revenue: | $1,012,216,000 | Revenue Growth: | 20.66% |
| Revenue Growth (this year): | 7.37% | Revenue Growth (next year): | -0.06% |
Latest Macerich Company (The) News
MAC Breaking Stock News: Dive into MAC Ticker-Specific Updates for Smart Investing
Zacks
8 days ago
Is it Wise to Retain Macerich Stock in Your Portfolio Now?
TipRanks
10 days ago
McDonald’s downgraded on GLP-1 drug worries: Wall Street’s top analyst calls
Argus Research
11 days ago
MAC: What does Argus have to say about MAC?
MT Newswires
11 days ago
Macerich Shares Rise After Upgrade From Mizuho
Investing.com
11 days ago
Mizuho upgrades Macerich as its sees risk-reward favorable
MT Newswires
11 days ago
Mizuho Upgrades Macerich to Outperform From Neutral, Adjusts Price Target to $18 From $22
MT Newswires
12 days ago
Truist Adjusts Price Target on Macerich to $21 From $19, Maintains Buy Rating
Morningstar Research
a month ago
Analyst Report: The Macerich Company
Compare MAC vs Leading Stocks
Share on Social Networks:
Disclaimer
The information presented on this page, "MAC Macerich Company (The) - Stocks Price | History | Analysis", including historical data, forecasts, news, insider information, and predictions, is provided for educational purposes only. It should not be considered as financial advice or a recommendation to buy or sell any securities. Decisions regarding investments should be made only after careful consideration and consultation with a qualified financial advisor. We do not endorse or guarantee the accuracy or reliability of the information provided, and we disclaim any liability for financial losses incurred as a result of decisions made based on the information presented.